Senescent T Cells in Age-Related Diseases

Age -induced alterations in human immunity are often considered deleterious and are referred to as immunosenescence. The immune system monitors the number of senescent cells in the body, while immunosenescence may represent the initiation of systemic aging. Immune cells, particularly T cells, are the most impacted and involved in age -related immune function deterioration, making older individuals more prone to different age -related diseases. T -cell senescence can impact the effectiveness of immunotherapies that rely on the immune system's function, including vaccines and adoptive T -cell therapies. The research and practice of using senescent T cells as therapeutic targets to intervene in age -related diseases are in their nascent stages. Therefore, in this review, we summarize recent related literature to investigate the characteristics of senescent T cells as well as their formation mechanisms, relationship with various aging -related diseases, and means of intervention. The primary objective of this article is to explore the prospects and possibilities of therapeutically targeting senescent T cells, serving as a valuable resource for the development of immunotherapy and treatment of age -related diseases.